Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Other Non-Current Assets (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Other Non-Current Assets came in at $387 million for Q2 2026, down 17.7% from $470 million a year earlier but up 2.7% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Other Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries' Other Non-Current Assets was $405 million, down 12.3% from FY2024.

  • Other Non-Current Assets carries a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Assets was $462 million in FY2024 (-1.7%), $470 million in FY2023 (+6.6%), $441 million in FY2022 (-14.4%) and $515 million in FY2021 (-4.3%).
  • The five-year range for quarterly Other Non-Current Assets is $377 million (Q1 2026) to $518 million (Q3 2021).
  • Year-over-year, Other Non-Current Assets has declined for four consecutive quarters, with an average decline of 6.3% over the last eight quarters.
  • The fastest year-over-year change in Other Non-Current Assets over five years came in Q3 2023 (growth of 8.9%), and the weakest in Q3 2021 (a decline of 37.0%).
  • Business Quant data shows TEVA's Other Non-Current Assets at $377 million (Q1 2026), $405 million (Q4 2025) and $444 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 14.27 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.73 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 387.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 387.00 Mn
Mar 31, 2026 377.00 Mn
Dec 31, 2025 405.00 Mn
Sep 30, 2025 444.00 Mn
Jun 30, 2025 470.00 Mn
Mar 31, 2025 464.00 Mn
Dec 31, 2024 462.00 Mn
Sep 30, 2024 459.00 Mn
Jun 30, 2024 434.00 Mn
Mar 31, 2024 470.00 Mn
Dec 31, 2023 470.00 Mn
Sep 30, 2023 477.00 Mn
Jun 30, 2023 443.00 Mn
Mar 31, 2023 450.00 Mn
Dec 31, 2022 441.00 Mn
Sep 30, 2022 438.00 Mn
Jun 30, 2022 454.00 Mn
Mar 31, 2022 472.00 Mn
Dec 31, 2021 515.00 Mn
Sep 30, 2021 518.00 Mn
API Access

Teva Pharmaceutical Industries Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TEVA&period=max&api_key=YOUR_API_KEY